@article{7153027c6f734de18d4c26808d09f3ed,
title = "Why We Should Care About Who Cares for Patients With Heart Failure With Preserved Ejection Fraction",
keywords = "Editorials, cardiology, healthcare providers, heart failure, hospitalization, process assessment (health care)",
author = "Shah, {Sanjiv J.}",
note = "Funding Information: Dr Shah has received research grants from the National Institutes of Health (U54 HL160273, R01 HL107577, R01 HL127028, R01 HL140731, R01 HL149423), Actelion, AstraZeneca, Corvia, Novartis, and Pfizer and has received consulting fees from Abbott, Actelion, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiora, Coridea, CVRx, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Eisai, Imara, Impulse Dynamics, Intellia, Ionis, Ironwood, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sanofi, Shifamed, Tenax, Tenaya, and United Therapeutics.",
year = "2022",
month = aug,
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.122.009867",
language = "English (US)",
volume = "15",
pages = "E009867",
journal = "Circulation: Heart Failure",
issn = "1941-3289",
publisher = "Lippincott Williams and Wilkins",
number = "8",
}